General

• What is Healthcare Biotechnology?
• What is different about biotech treatments?
• What are the facts and figures for healthcare biotechnology?
• What kind of treatments can healthcare biotech provide for the patients?
• How are biological medicines manufactured?
• Why do they cost so much?
• What are personalized medicines?
• How are personalized medicines and biotechnology related?
• What is EuropaBio’s position on animal welfare?

Biosimilars

• Why do biological medicines differ from chemical medicines?
• How are biological medicines manufactured?
• Where does the word “biosimilar” come from?
• What is a biosimilar medicine?
• What do I have to consider as a patient using biosimilar medicine?

Rare Diseases

• What is a rare disease?
• What is an orphan disease?
• What is an “orphan drug"?
• Is there a European Regulation to encourage the development of orphan drugs?
• Why does there need to be a European Regulation about orphan drugs?
• Why are biotech drugs relevant to orphan diseases?

Advanced therapies

• What are "advanced therapies"?
• What are the types of advanced therapies?
• What is the Regulation for Advanced Therapies in Europe?

Health Technology Assessment (HTA)

• What is ‘health technology’?
• What is Health Technology Assessment?
• What is the aim of Health Technology Assessment?
• Is there a common European consensus to reward healthcare innovation in HTAs?
• What can be done to improve HTAs?
• Should HTAs include a broader perspective?
• What about early-stage dialogues on these assessments?
• How could greater flexibility play a role?
• Is there such a thing as the “right” timing?
• Could HTAs manage uncertainty more effectively?
• Should there be patient and public involvement in HTAs?
• What could make HTAs more industry-friendly?